Advertisement
Review Article| Volume 4, ISSUE 1, P243-251, September 2022

Download started.

Ok

Contrast-Enhanced Mammography for Practicing Radiologists

Clinical Indications, Technique, and Interpretation

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Clinical Radiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Francescone M.A.
        • Jochelson M.S.
        • Dershaw D.D.
        • et al.
        Low energy mammogram obtained in contrast-enhanced digital mammography (CEDM) is comparable to routine full-field digital mammography (FFDM).
        Eur J Radiol. 2014; 83: 1350-1355
        • Sensakovic W.F.
        • Carnahan M.B.
        • Czaplicki C.D.
        • et al.
        Contrast-enhanced Mammography : how does it work.
        Radiographics. 2021; 41: 829-839
        • Jochelson M.S.
        • Lobbes M.B.I.
        Contrast-enhanced mammography : state of the ART.
        Radiology. 2021; 299: 36-48
        • Ghaderi K.F.
        • Phillips J.
        • Perry H.
        • et al.
        Contrast-enhanced mammography: current applications and future directions.
        Radiographics. 2019; 39: 1907-1920
        • Lewin J.
        Comparison of contrast-enhanced mammography and contrast-enhanced breast MR imaging.
        Magn Reson Imaging Clin N Am. 2018; 26: 259-263
        • American College of Radiology
        Contrast enhanced mammography imaging screening trial (CMIST).
        (Available at:) (Accessed January 26, 2022)
        • Lobbes M.B.I.
        • Lalji U.
        • Houwers J.
        • et al.
        Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme.
        Eur Radiol. 2014; 24: 1668-1676
        • Lalji U.C.
        • Houben I.P.L.
        • Prevos R.
        • et al.
        Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study.
        Eur Radiol. 2016; 26: 4371-4379
        • Zuley M.L.
        • Bandos A.I.
        • Abrams G.S.
        • et al.
        Contrast enhanced digital mammography (CEDM) helps to safely reduce benign breast biopsies for low to moderately suspicious soft tissue lesions.
        Acad Radiol. 2020; 27: 969-976
        • James J.J.
        • Tennant S.L.
        Contrast-enhanced spectral mammography (CESM).
        Clin Radiol. 2018; 73: 715-723
        • Houben I.P.L.
        • Vanwetswinkel S.
        • Kalia V.
        • et al.
        Contrast-enhanced spectral mammography in the evaluation of breast suspicious calcifications: diagnostic accuracy and impact on surgical management.
        Acta Radiol. 2019; 60: 1110-1117
        • Goh Y.
        • Chan C.W.
        • Pillay P.
        • et al.
        Architecture distortion score (ADS) in malignancy risk stratification of architecture distortion on contrast-enhanced digital mammography.
        Eur Radiol. 2021; 31: 2657-2666
        • Patel B.K.
        • Naylor M.E.
        • Kosiorek H.E.
        • et al.
        Clinical utility of contrast-enhanced spectral mammography as an adjunct for tomosynthesis-detected architectural distortion.
        Clin Imaging. 2017; 46: 44-52
        • Sudhir R.
        • Sannapareddy K.
        • Potlapalli A.
        • et al.
        Diagnostic accuracy of contrast-enhanced digital mammography in breast cancer detection in comparison to tomosynthesis, synthetic 2D mammography and tomosynthesis combined with ultrasound in women with dense breast.
        Br J Radiol. 2021; 94: 1-8
        • Luczyńska E.
        • Heinze S.
        • Adamczyk A.
        • et al.
        Comparison of the mammography CESM and US in a group of 116 patients.
        Anticancer Res. 2016; 4366: 4359-4366
        • Tennant S.L.
        • James J.J.
        • Cornford E.J.
        • et al.
        Contrast-enhanced spectral mammography improves diagnostic accuracy in the symptomatic setting.
        Clin Radiol. 2016; 71: 1148-1155
        • Sorin V.
        • Faermann R.
        • Yagil Y.
        • et al.
        Contrast-enhanced spectral mammography (CESM) in women presenting with palpable breast findings.
        Clin Imaging. 2020; 61: 99-105
        • Patel B.K.
        • Garza S.A.
        • Eversman S.
        • et al.
        Assessing tumor extent on contrast-enhanced spectral mammography versus full-field digital mammography and ultrasound.
        Clin Imaging. 2017; 46: 78-84
        • Zamora K.
        • Allen E.
        • Hermecz B.
        Contrast mammography in clinical practice: current uses and potential diagnostic dilemmas.
        Clin Imaging. 2021; 71: 126-135
        • Kim E.Y.
        • Youn I.
        • Lee K.H.
        • et al.
        Diagnostic value of contrast-enhanced digital mammography versus contrast-enhanced magnetic resonance imaging for the preoperative evaluation of breast cancer.
        J Breast Cancer. 2018; 21: 453-462
        • Xiang W.
        • Rao H.
        • Zhou L.
        A meta-analysis of contrast-enhanced spectral mammography versus MRI in the diagnosis of breast cancer.
        Thorac Cancer. 2020; 11: 1423-1432
        • Tardivel A.M.
        • Balleyguier C.
        • Dunant A.
        • et al.
        Added value of contrast-enhanced spectral mammography in postscreening assessment.
        Breast J. 2016; 22: 520-528
        • Sogani J.
        • Mango V.L.
        • Keating D.
        • et al.
        Contrast-enhanced mammography: past, present, and future.
        Clin Imaging. 2021; 69: 269-279
        • Lobbes M.B.I.
        • Prevos R.
        • Smidt M.
        • et al.
        The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review.
        Insights Imaging. 2013; 4: 163-175
        • Rosen E.L.
        • Blackwell K.L.
        • Baker J.A.
        • et al.
        Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy.
        Am J Roentgenol. 2003; 181: 1275-1282
        • Iotti V.
        • Ravaioli S.
        • Vacondio R.
        • et al.
        Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.
        Breast Cancer Res. 2017; 19: 1-13
        • Tang S.
        • Xiang C.
        • Yang Q.
        The diagnostic performance of CESM and CE-M RI in evaluating the pathological response to neoadjuvant therapy in breast cancer: a systematic review and meta-analysis.
        Br J Radiol. 2020; 93: 20200301
        • Lee C.S.
        • Monticciolo D.L.
        • Moy L.
        Screening guidelines update for average-risk and high-risk women.
        Am J Roentgenol. 2020; 214: 316-323
        • Wang L.
        • Strigel R.M.
        Supplemental screening for patients at intermediate and high risk for breast cancer.
        Radiol Clin North Am. 2021; 59: 67-83
        • Jochelson M.S.
        • Pinker K.
        • Dershaw D.D.
        • et al.
        Comparison of screening CEDM and MRI for women at increased risk for breast cancer: a pilot study.
        Eur J Radiol. 2017; 97: 37-43
        • Sung J.S.
        • Lebron L.
        • Keating D.
        • et al.
        Performance of dual-energy contrast-enhanced digital mammography for screening women at increased risk of breast cancer.
        Radiology. 2019; 293: 81-88
        • Sorin V.
        • Yagil Y.
        • Yosepovich A.
        • et al.
        Contrast-enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts.
        Am J Roentgenol. 2018; 211: W267-W274
        • Covington M.F.
        Contrast-enhanced mammography implementation, performance, and use for supplemental breast cancer screening.
        Radiol Clin North Am. 2021; 59: 113-128
        • Weigel S.
        • Heindel W.
        • Heidrich J.
        • et al.
        Digital mammography screening: sensitivity of the programme dependent on breast density.
        Eur Radiol. 2017; 27: 2744-2751
        • Carney P.A.
        • Miglioretti D.L.
        • Yankaskas B.C.
        • et al.
        Erratum: Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography (Annals of Internal Medicine (2003) 138 (168-175.
        Ann Intern Med. 2003; 138: 771
        • Gluskin J.
        • Saccarelli C.R.
        • Avendano D.
        • et al.
        Contrast-enhanced mammography for screening women after breast conserving surgery.
        Cancers (Basel). 2020; 12: 1-14
        • Mori M.
        • Akashi-Tanaka S.
        • Suzuki S.
        • et al.
        Diagnostic accuracy of contrast-enhanced spectral mammography in comparison to conventional full-field digital mammography in a population of women with dense breasts.
        Breast Cancer. 2017; 24: 104-110
        • Cheung Y.C.
        • Lin Y.C.
        • Wan Y.L.
        • et al.
        Diagnostic performance of dual-energy contrast-enhanced subtracted mammography in dense breasts compared to mammography alone: interobserver blind-reading analysis.
        Eur Radiol. 2014; 24: 2394-2403
      1. ACR Committee on drugs and contrast Media. ACR Manual on Contrast Media.
        (Available at:) (Accessed September 13, 2021)
        • Glover M.
        • Daye D.
        • Khalilzadeh O.
        • et al.
        Socioeconomic and demographic predictors of missed opportunities to provide advanced imaging services.
        J Am Coll Radiol. 2017; 14: 1403-1411
        • Phillips J.
        • Mihai G.
        • Hassonjee S.E.
        • et al.
        Comparative dose of contrast-enhanced spectral mammography (CESM), digital mammography, and digital breast tomosynthesis.
        Am J Roentgenol. 2018; 211: 839-846
        • Clauser P.
        • Baltzer P.A.T.
        • Kapetas P.
        • et al.
        Low-dose, contrast-enhanced mammography compared to contrast-enhanced breast MRI: a feasibility study.
        J Magn Reson Imaging. 2020; 52: 589-595
        • Neeter L.M.F.H.
        • Houben I.P.L.
        • Nelemans P.J.
        • et al.
        Rapid Access to Contrast-Enhanced spectral mammogRaphy in women recalled from breast cancer screening: The RACER trial study design.
        Trials. 2019; 20: 1-10
        • Chou C.P.
        • Lewin J.M.
        • Chiang C.L.
        • et al.
        Clinical evaluation of contrast-enhanced digital mammography and contrast enhanced tomosynthesis - Comparison to contrast-enhanced breast MRI.
        Eur J Radiol. 2015; 84: 2501-2508